Evidence map›Paper›PMID 39714270›Full record

ArticleEmerging infectious diseases2025

Meningococcal C Disease Outbreak Caused by Multidrug-Resistant Neisseria meningitidis, Fiji.

Aneley Getahun Strobel, Aalisha Sahukhan, Anaseini Ratu, Jimaima Kailawadoko, Isireli Koroituku, Shalini Singh, Samuel McEwen, Sakiusa Baleivanualala, Mathilda Wilmot, Silivia Matanitobua and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Aneley Getahun Strobel
Aalisha Sahukhan
Anaseini Ratu
Jimaima Kailawadoko
Isireli Koroituku
Shalini Singh
Samuel McEwen
Sakiusa Baleivanualala
Mathilda Wilmot
Silivia Matanitobua
Kerrie Stevens
Anaseini Vesikula
Talica Cabemaiwai
Raquel Cooper
Mere Taufa
Jokaveti Tadrau
Kristy Horan
Daniel Faktaufon
Benjamin P Howden
Eric Rafai

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe an outbreak of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup C in Fiji. We created surveillance case definitions and collected data by using standard investigation forms. Bacterial identification, antimicrobial susceptibility testing, and PCR were performed in Fiji. Molecular testing was conducted at the Microbiological Diagnostic Unit in Melbourne, Victoria, Australia. During January 2016-December 2018, a total of 96 confirmed or probable IMD cases were reported. Of case-patients, 61.5% (59/96) were male and 38.5% (37) female, 84.4% (81) were indigenous people of Fiji, and 70.8% (68) were children <15 years of age. Annual incidence increased from 1.8/100,000 population in 2016 to 5.2/100,000 population in 2018. Serogroup C multilocus serotype 4821 that is resistant to ciprofloxacin was prevalent (62.1%, 41/66). Public health measures, which included targeted mass vaccination with monovalent meningitis C vaccine, were effective in controlling the outbreak. We observed a rapid decline in meningitis C cases in subsequent years.

Indexed as

Disease OutbreaksDrug Resistance, Multiple, BacterialMeningitis, MeningococcalAdolescentAdultAnti-Bacterial AgentsChildChild, PreschoolFemaleFijiHumansIncidenceInfantMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial Agentsantimicrobial resistanceBacteriadrug resistanceepidemiologyFijimeningitis/encephalitismeningococcal CmeningococcusNeisseria meningitidisOceaniaoutbreaksvaccination

Identifiers

PMID39714270
PMCPMC11682797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.